Copyright
©The Author(s) 2023.
World J Radiol. Jan 28, 2023; 15(1): 20-31
Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.20
Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.20
Table 1 Locations, numbers, and frequencies of salivary gland tumors
Location | n (%) |
Unilateral parotid gland | 61 (83.6) |
Submandibular gland | 6 (8.2) |
Minor salivary gland | 3 (4.1) |
Bilateral parotid gland | 2 (2.7) |
Sublingual gland | 1 (1.4) |
Table 2 Numbers of benign and malignant salivary gland tumors
Benign SGTs | n (%) | Malignant SGTs | n (%) |
Warthin’s tumor | 18 (24.7) | Squamous cell carcinoma | 11 (15.1) |
Pleomorphic adenoma | 14 (19.2) | Adenoid cystic carcinoma | 3 (4.1) |
Inflammatory process | 12 (16.4) | Malignant lymphoma | 3 (4.1) |
Lipoma | 4 (5.5) | Adenocarcinoma | 1 (1.4) |
Benign cystic lesions | 1 (1.4) | Mucoepidermoid carcinoma | 1 (1.4) |
Carcinoma ex pleomorphic adenoma | 1 (1.4) | ||
Other benign lesions | 1 (1.4) | Acinic cell carcinoma | 1 (1.4) |
Follicular dendritic cell sarcoma | 1 (1.4) | ||
Salivary duct carcinoma | 1 (1.4) | ||
Total | 50 (68.5) | 23 (31.5) |
Table 3 Mean ADC values and quantitative dynamic contrast-enhanced magnetic resonance imaging parameters of different histopathologic salivary gland tumors
Pleomorphic adenoma | Warthin’s tumor | Other benign tumors | Malignant tumors | P value | |
ADC (× 10−3 mm2/s) | 1.61 ± 0.26 (a) | 0.72 ± 0.09 (b) | 0.77 ± 0.19 (b) | 0.96 ± 0.33 (b) | < 0.001 |
Ktrans (min−1) | 0.42 ± 0.35 | 0.75 ± 0.55 | 0.57 ± 0.37 | 0.77 ± 0.56 | 0.131 |
Kep (min−1) | 0.69 ± 0.33 (a) | 6.2 ± 3.13 (b) | 1.95 ± 0.94 (c) | 1.72 ± 0.92 (c) | < 0.001 |
Ve | 0.65 ± 0.25 (a) | 0.11 ± 0.04 (b) | 0.3 ± 0.12 (c) | 0.48 ± 0.24 (ac) | < 0.001 |
Table 4 Semiquantitative dynamic contrast-enhanced magnetic resonance imaging parameters of different histopathologic salivary gland tumors
TIC Pattern, n(%) | Tpeak (s) | WR (%) | ||||
A | B | C | D | |||
Pleomorphic adenomas | 14 (70.0) | 0 (0) | 0 (0) | 0 (0) | 202.74 ± 21.48 (a) | - |
Warthin’s tumors | 0 (0) | 18 (66.7) | 0 (0) | 0 (0) | 20.26 ± 11.72 (b) | 59.33 ± 10.99 (a) |
Other benign tumors | 4 (20.0) | 4 (14.8) | 10 (45.5) | 0 (0) | 74.94 ± 75.47 (c) | 17.89 ± 14.99 (b) |
Malignant tumors | 2 (10.0) | 5 (18.5) | 12 (54.5) | 4 (100) | 60.60 ± 55.78 (c) | 18.48 ± 18.38 (b) |
P value | < 0.001 | < 0.001 | < 0.001 |
Table 5 Comparison of pleomorphic adenomas, Warthin’s tumors, and malignant salivary gland tumors by ROC analysis using ADC, Tpeak, Ktrans, Kep, and Ve values
Variable | Cut-off | AUC (95% CI) | Sensitivity | Specificity | PPV | NPV | P value |
Pleomorphic adenomas | |||||||
ADC value | > 1.1 | 0.977 (0.911-0.998) | 1.000 | 0.898 | 0.700 | 1.000 | < 0.001 |
Tpeak | > 120 | 0.947 (0.868-0.986) | 1.000 | 0.898 | 0.700 | 1.000 | < 0.001 |
Ktrans | ≤ 0.46 | 0.702 (0.584-0.804) | 0.857 | 0.627 | 0.353 | 0.949 | 0.005 |
Kep | ≤ 1.14 | 0.926 (0.840-0.974) | 0.929 | 0.831 | 0.565 | 0.980 | < 0.001 |
Ve | ≥ 0.4 | 0.849 (0.746-0.922) | 0.929 | 0.729 | 0.448 | 0.977 | < 0.001 |
Warthin’s tumors | |||||||
ADC value | ≤ 0.8 | 0.742 (0.626-0.837) | 0.944 | 0.582 | 0.425 | 0.970 | < 0.001 |
Tpeak | ≤ 19.1 | 0.869 (0.769-0.936) | 0.667 | 0.909 | 0.706 | 0.893 | < 0.001 |
WR | > 43 | 0.981 (0.917-0.999) | 0.944 | 0.909 | 0.773 | 0.980 | < 0.001 |
Ktrans | > 0.3 | 0.577 (0.455-0.692) | 0.889 | 0.346 | 0.308 | 0.905 | 0.291 |
Kep | > 2.44 | 0.973 (0.905-0.997) | 1.000 | 0.855 | 0.692 | 1.000 | < 0.001 |
Ve | ≤ 0.17 | 0.958 (0.883-0.991) | 1.000 | 0.909 | 0.783 | 1.000 | < 0.001 |
Malignant tumors | |||||||
ADC value | > 0.7 | 0.541 (0.420-0.658) | 0.783 | 0.440 | 0.391 | 0.815 | 0.569 |
Tpeak | ≤ 120 | 0.531 (0.410-0.649) | 0.913 | 0.360 | 0.396 | 0.900 | 0.648 |
WR | ≤ 49 | 0.562 (0.441-0.678) | 1.000 | 0.300 | 0.397 | 1.000 | 0.351 |
Ktrans | > 0.53 | 0.599 (0.477-0.712) | 0.652 | 0.600 | 0.429 | 0.789 | 0.194 |
Kep | ≤ 3.7 | 0.592 (0.471-0.706) | 1.000 | 0.300 | 0.397 | 1.000 | 0.160 |
Ve | > 0.35 | 0.702 (0.584-0.804) | 0.696 | 0.660 | 0.485 | 0.825 | 0.001 |
- Citation: Gökçe E, Beyhan M. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors. World J Radiol 2023; 15(1): 20-31
- URL: https://www.wjgnet.com/1949-8470/full/v15/i1/20.htm
- DOI: https://dx.doi.org/10.4329/wjr.v15.i1.20